Men vs women with spontaneous intracerebral hemorrhage (ICH) have a higher risk for deep bleeds but a lower risk for poor outcomes.

Dementia risk is nearly 80% higher in stroke survivors than in those without stroke, with risk declining within 1 year but ...

Over the past 3 decades, age-standardized stroke burden rates have declined worldwide, although some areas have seen increases in mortality rates.

Patients afflicted with intracerebral hemorrhage (ICH) experience potentially devastating neurological sequelae; current therapy for ICH remains supportive. However, hemostatic therapy with ...

CLPH-291 is under clinical development by Cellphire and currently in Phase II for Wiskott-Aldrich Syndrome. According to GlobalData, Phase II drugs for Wiskott-Aldrich Syndrome have a 100% phase ...

A North Texas neurologist discusses brain bleeds - the medical emergency that ultimately sidelined actor and comedian Jamie ...

The belief that stroke only happens among older adults may not be true anymore. While older people are more likely to suffer ...

Foralumab is under clinical development by Tiziana Life Sciences and currently in Phase III for Secondary Progressive Multiple Sclerosis (SPMS).

After 30 years of disappointment, 2 randomized controlled trials investigating the effect of neurosurgical treatment on functional outcome in patients with intracerebral hemorrhage were published in ...